1. Home
  2. DARE vs NINE Comparison

DARE vs NINE Comparison

Compare DARE & NINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • NINE
  • Stock Information
  • Founded
  • DARE 2015
  • NINE 2011
  • Country
  • DARE United States
  • NINE United States
  • Employees
  • DARE N/A
  • NINE N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • NINE Oilfield Services/Equipment
  • Sector
  • DARE Health Care
  • NINE Energy
  • Exchange
  • DARE Nasdaq
  • NINE Nasdaq
  • Market Cap
  • DARE 26.3M
  • NINE 23.8M
  • IPO Year
  • DARE N/A
  • NINE 2018
  • Fundamental
  • Price
  • DARE $2.38
  • NINE $0.76
  • Analyst Decision
  • DARE Strong Buy
  • NINE
  • Analyst Count
  • DARE 3
  • NINE 0
  • Target Price
  • DARE $12.50
  • NINE N/A
  • AVG Volume (30 Days)
  • DARE 40.1K
  • NINE 8.6M
  • Earning Date
  • DARE 08-11-2025
  • NINE 08-05-2025
  • Dividend Yield
  • DARE N/A
  • NINE N/A
  • EPS Growth
  • DARE N/A
  • NINE N/A
  • EPS
  • DARE N/A
  • NINE N/A
  • Revenue
  • DARE $25,909.00
  • NINE $562,450,000.00
  • Revenue This Year
  • DARE $99,756.91
  • NINE $3.64
  • Revenue Next Year
  • DARE $119.77
  • NINE N/A
  • P/E Ratio
  • DARE N/A
  • NINE N/A
  • Revenue Growth
  • DARE N/A
  • NINE N/A
  • 52 Week Low
  • DARE $2.35
  • NINE $0.44
  • 52 Week High
  • DARE $4.60
  • NINE $2.02
  • Technical
  • Relative Strength Index (RSI)
  • DARE 34.73
  • NINE 50.73
  • Support Level
  • DARE $2.56
  • NINE $0.73
  • Resistance Level
  • DARE $2.95
  • NINE $1.55
  • Average True Range (ATR)
  • DARE 0.12
  • NINE 0.17
  • MACD
  • DARE -0.05
  • NINE 0.01
  • Stochastic Oscillator
  • DARE 8.45
  • NINE 23.09

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

Share on Social Networks: